# Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular Carcinoma

> **NCT01088581** · PHASE3 · COMPLETED · sponsor: **Yonsei University** · enrollment: 101 (actual)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

- **DRUG:** Adjuvant group

## Key facts

- **NCT ID:** NCT01088581
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-01
- **Primary completion:** 2007-12
- **Final completion:** 2008-12
- **Target enrollment:** 101 (ACTUAL)
- **Last updated:** 2012-02-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01088581

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01088581, "Adjuvant Hepatic Arterial Infusional Chemotherapy After Curative Resection of Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT01088581. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*